The age of onset and sex distribution are similar to that of pemphigus foliaceus (approximately 50 years, occurs equally in men and women). Like other forms of pemphigus, pemphigus erythematosus is very rare in children.
Pemphigus erythematosus may persist almost indefinitely as a localized disease. Despite its name, most patients with pemphigus erythematosus do not develop signs of systemic lupus erythematosus (SLE). Patients with pemphigus erythematosus who also meet the American College of Rheumatology criteria for systemic lupus are said to have both conditions simultaneously.
Both clinically and immunopathologically, pemphigus erythematosus combines features of pemphigus and lupus. Patients have intercellular autoantibodies and subcorneal acantholysis as seen in pemphigus foliaceus. Patients also frequently have positive antinuclear antibodies (ANA) and a positive lupus band on direct immunofluorescence.
Pemphigus erythematosus occurs with increased frequency in patients with a history of thymoma, myasthenia gravis, and other autoimmune diseases. Some of these patients also have autoantibodies directed against striated muscle. Certain HLA subtypes are represented more frequently in pemphigus erythematosus (HLA-A10, HLA-A26, HLA-DRW6).
Pemphigus erythematosus can be drug induced. The most notable medications associated with this condition are d-penicillamine and captopril. Both of these agents contain a highly negatively charged sulfhydryl group that has been implicated as the potential cause of acantholysis. There are also reports of drug-induced pemphigus erythematosus with ceftazidime, propranolol, pyritinol, and heroin.
Pemphigus erythematosus has been reported to occur in lesions of ultraviolet burns and thermal burns. More rarely, pemphigus erythematosus has been reported to occur in the setting of malignancy, most commonly bronchogenic carcinoma.
In a 2003 article describing an outbreak of endemic pemphigus in Northern Columbia, pemphigus erythematosus was the primary clinical phenotype. On examination, most of the patients showed keratotic follicular skin lesions resembling discoid lupus erythematosus, a high degree of photosensitivity, and a lupus band-like deposition of immunoglobulins and complement at the basement membrane zone.
Pemphigus erythematosus is less likely to rapidly progress than other forms of pemphigus and responds to similar immunosuppressant therapies.
L10.4 – Pemphigus erythematosus
36739006 – Pemphigus erythematosus
- Pemphigus foliaceus – Presents with widespread crusted erosions involving predominantly the face, chest, and back.
- Polymorphous light eruption
- Lupus erythematous, subacute – Characteristic histopathology and usually positive for ANA and anti-Ro.
- Pemphigus vulgaris and SLE
- Impetigo – Acute development of inflamed crusted erosions that are often quite painful.
- Seborrheic dermatitis – Chronic eczematous dermatitis in the absence of blistering and autoantibodies.
Last Updated: 06/26/2018